CA9 and neoplasm: Diagnostic Positron Emission Tomography (PET) imaging with girentuximab radiolabelled with either positron-emitting iodine-124 or zirconium-89 has shown potential to be of use in identifying CAIX positive tumours (Cheal et al. 2014).